Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

December 31, 2012

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Paclitaxel/Carboplatin/Gefitinib

paclitaxel (175mg/m2 on day 1)/carboplatin (AUC 5 on day 1)/daily gefitinib 250mg/day during day 2-15

DRUG

Paclitaxel/Carboplatin

paclitaxel (175mg/m2 on day 1)/carboplatin (AUC 5 on day 1)

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Asan Medical Center

OTHER